Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers.

MLA

Nock, Sebastian, et al. “Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers.” Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, vol. 128, no. 6-07, June 2020, pp. 473–78. EBSCOhost, https://doi.org/10.1055/a-1012-8484.

APA

Nock, S., Höfig, C., Harder, L., Schomburg, L., Brabant, G., & Mittag, J. (2020). Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, 128(6-07), 473–478. https://doi.org/10.1055/a-1012-8484

Chicago

Nock, Sebastian, Carolin Höfig, Lisbeth Harder, Lutz Schomburg, Georg Brabant, and Jens Mittag. 2020. “Unraveling the Molecular Basis for Successful Thyroid Hormone Replacement Therapy: The Need for New Thyroid Tissue- and Pathway-Specific Biomarkers.” Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association 128 (6-07): 473–78. doi:10.1055/a-1012-8484.